Ophthalmic Viscosurgical Devices Market by Product (Cohesive, Combined, Dispersive), Application (Cataract Surgery, Glaucoma Surgery, Keratoplasty), End User - Global Forecast 2024-2030

[187 Pages Report] The Ophthalmic Viscosurgical Devices Market size was estimated at USD 648.33 million in 2023 and expected to reach USD 702.86 million in 2024, at a CAGR 8.81% to reach USD 1,171.29 million by 2030.

Ophthalmic viscosurgical devices (OVDs) are sterile, viscoelastic devices that are used in eye surgery, primarily during cataract extraction and intraocular lens implantation, as well as in corneal transplantation surgery, glaucoma filtration, and retinal attachment procedures. These devices have unique viscoelastic properties that enable them to maintain eye tissue separation, stabilize ocular structures, protect endothelial cells, and create space within the eye during surgery. Meanwhile, the rising cases of ophthalmic and ocular diseases have propelled the demand for OVDs. However, the stringent government regulations associated with OVDs and the limited availability of invasive and non-invasive treatment options are significant challenges manufacturers face. Companies are frequently working towards adhering to government regulations and researching biocompatible materials or excretable to remain agile within the global space. Moreover, developing advanced OVDs with improved viscoelastic properties, lower toxicity, and enhanced ease of use during surgery presents potential opportunities for the companies. Additionally, expanding markets in emerging economies due to increasing healthcare infrastructure investments offer new avenues for growth.

In the Americas, the United States and Canada witnessed significant growth in the OVD market for ophthalmic viscosurgical devices, with a highly developed healthcare system and widespread adoption of cataract and refractive surgeries. Patient preference for minimally invasive procedures drives innovations and usage of premium OVD products in this region. In addition, Latin American countries are progressively adopting modern ophthalmic surgical devices, influenced by gradual improvements in healthcare infrastructure. On the other hand, Europe has a well-established market for OVDs, with a strong emphasis on quality and regulatory compliance alongside robust healthcare systems. The European Union's demand for OVDs aligns with an aging population and high surgical standards, while the Middle Eastern market benefits from rising investments in healthcare facilities and a growing medical tourism industry. Moreover, the Asia Pacific region demonstrates a significant and growing demand for OVDs due to the increasing prevalence of ophthalmic conditions such as cataracts and glaucoma, especially in populous countries such as China and India. Advanced research and development facilities in Japan contribute to innovative OVD formulations, increasing the demand for OVDs.

The market dynamics represent an ever-changing landscape of the Ophthalmic Viscosurgical Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Rising Cases of the Ophthalmic and Ocular Disorders
  • Availability of Well-Equipped Healthcare Infrastructure and Increasing Number of Drugs Approvals
• Market Restraints
  • Availability of Minimally Invasive and Non-Invasive Treatment Options
• Market Opportunities
  • Introduction of New Types of Ophthalmic Viscosurgical Devices
  • Ongoing Clinical Consideration of Adhesive for Ophthalmic Viscosurgeries
• Market Challenges
  • Limited Availability of Skilled Professionals for Ophthalmic Procedures

• Product: Growing popularity of cohesive and dispersive OVDs due to their versatility and surgical safety

  Ophthalmic viscosurgical devices (OVDs) are pivotal in ocular surgeries, particularly during cataracts and corneal operations. These viscoelastic agents are categorized based on their physical properties and surgical applicability. Cohesive OVDs, known for their high molecular weight and elasticity, maintain a singular mass, facilitating easy removal from the anterior chamber. They are often used to hold space in the eye and manipulate tissues. Dispersive OVDs, with their lower molecular weight and viscosity, provide superior endothelial protection by creating a thin layer that coats the corneal endothelium. This makes them ideal during phacoemulsification, protecting the corneal endothelium from potential damage caused by surgical instruments or lens fragments. Meanwhile, combined OVDs, also known as viscoadaptive OVDs, offer a versatile solution that exhibits properties of both cohesive and dispersive types. They adapt to changes in surgical conditions, providing cohesive properties under low-flow situations while behaving as dispersive OVDs under high-shear conditions. Each type serves a specific purpose, and their application is crucial for the success and safety of ophthalmic procedures.

• Application: Increasing uses of OVDs in cataract and keratoplasty surgeries offering clear visualizations while ensuring patient’s safety

  Ophthalmic viscosurgical devices (OVDs) are crucial in enhancing safety and improving outcomes in various eye surgeries. In cataract surgery, OVDs are essential for maintaining anterior chamber depth, stabilizing eye structures, and protecting corneal endothelial cells during lens extraction and intraocular lens implantation. These devices provide clear visualization and facilitate the manipulation of tissues. During glaucoma surgery, OVDs help maintain the anterior chamber and prevent flat chamber complications postoperatively. They can also modulate the filtration rate in procedures such as trabeculectomy, preventing postoperative hypotony. In keratoplasty or corneal transplantation, OVDs preserve the corneal endothelium and provide space for surgical maneuvers. They contribute to the ease of donor cornea insertion and positioning, reduce trauma during suturing, and decrease postoperative edema, thereby enhancing the overall success of the procedure.

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Ophthalmic Viscosurgical Devices Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

The value chain of the Ophthalmic Viscosurgical Devices Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of theOphthalmic Viscosurgical Devices Market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

The regulatory framework analysis for the Ophthalmic Viscosurgical Devices Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Ophthalmic Viscosurgical Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Ophthalmic Viscosurgical Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

• Coherus is Selling Off Its Ophthalmology Franchise to Sandoz

  Coherus BioSciences, Inc., a biopharmaceutical firm, announced a strategic transaction agreement with Sandoz Group regarding its ophthalmic portfolio, including the significant CIMERLI (ranibizumab-earn), a biosimilar to the widely recognized treatment LUCENTIS. This deal underscores Coherus's commitment to enhancing patient care through innovation, particularly in the ophthalmology space. The company, known for its robust pipeline and expertise in advancing novel immunotherapies, primarily for oncology, is poised to broaden its impact within the ophthalmology market through this agreement. [Published On: January 23, 2024]

• Rayner Announces Acquisition of Sophi

  Rayner, acquiredThis AG is the Swiss originator and producer of cutting-edge Sophi phacoemulsification systems. This strategic move diversifies. Sophi, an acronym for Swiss Ophthalmology Innovation, epitomizes the epitome of surgical advancement with its mobility-focused design and user-centric features, including a triple pump fluidics system, high-precision Intraocular Pressure regulation, and innovative cable-free energy supply paired with wireless capabilities. Rayner's latest acquisition reflects its consistent dedication to revolutionizing eye care and enhancing ophthalmic surgery outcomes globally. [Published On: January 16, 2024]

• Bausch + Lomb Launches New Ophthalmic Viscosurgical Devices in the United States

  Bausch + Lomb expanded its suite of ophthalmic solutions with the launch of StableVisc, a novel cohesive ophthalmic viscosurgical device (OVD), and the TotalVisc Viscoelastic System in the United States. These offerings are engineered to deliver exceptional dual-action protection throughout cataract surgery. The distinctive feature of the StableVisc OVD is its ability to consistently hold open the anterior chamber of the eye, thus facilitating the smooth removal and insertion of the intraocular lens. [Published On: April 25, 2023]

The report delves into recent significant developments in the Ophthalmic Viscosurgical Devices Market, highlighting leading vendors and their innovative profiles. These include Bausch & Lomb Incorporated, Amring Pharmaceuticals Inc., Advin Health Care, SERVImed Industrial S.p.A., Rayner Group, Johnson & Johnson Services, Inc., Lifecore Biomedical, Inc., Bohus BioTech AB, Ophtechnics Unlimited, Fidia Farmaceutici S.p.A., Alcon Inc., Precision Lens, Truviz Ophthalmic, Ildong Hyaltech Co., Ltd., Bloomage Biotechnology Corporation Limited, Henan Universe Intraocular Lens Research and Manufacture Co., Ltd., ALBOMED GmbH, LG Chem Life Sciences, Beaver-Visitec International, Inc., Kewpie Corporation, CIMA Technology, Inc., Carl Zeiss AG, Advanced BioMatrix, Maxigen Biotech Inc., and Contipro a.s..

This research report categorizes the Ophthalmic Viscosurgical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Cohesive
  • Combined
  • Dispersive
• Application
  • Cataract Surgery
  • Glaucoma Surgery
  • Keratoplasty
• End User
  • Ambulatory Surgical Center
  • Eye Specialty Clinics
  • Hospitals

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

1. What is the current market size and projected growth?
2. Which products, segments, applications, and regions offer promising investment opportunities?
3. What are the prevailing technology trends and regulatory frameworks?
4. What is the market share and positioning of the leading vendors?
5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?